Profile data is unavailable for this security.
About the company
IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The Company develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The Company is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.
- Revenue in USD (TTM)0.00
- Net income in USD-88.35m
- Incorporated2021
- Employees80.00
- LocationIO Biotech IncOle Maaloes Veh 3COPENHAGEN 2200DenmarkDNK
- Websitehttps://www.iobiotech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Finch Therapeutics Group Inc | 0.00 | -14.17m | 21.28m | 18.00 | -- | 1.50 | -- | -- | -8.82 | -8.82 | 0.00 | 8.86 | 0.00 | -- | -- | -- | -25.20 | -- | -28.80 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -87.57 | -- | 34.80 | -- | -- | -- |
| Cue Biopharma Inc | 7.10m | -37.68m | 22.23m | 41.00 | -- | 1.66 | -- | 3.13 | -0.4553 | -0.4553 | 0.0823 | 0.1703 | 0.1857 | -- | 4.01 | 173,170.70 | -98.58 | -60.20 | -170.74 | -73.56 | -- | -- | -530.75 | -683.99 | -- | -- | 0.1107 | -- | 69.16 | 21.84 | 19.83 | -- | 7.32 | -- |
| Apollomics Inc | 8.50m | -31.19m | 22.25m | 13.00 | -- | -- | -- | 2.62 | -26.61 | -26.61 | 8.01 | -3.99 | 0.3721 | -- | -- | 653,846.10 | -136.51 | -- | -276.35 | -- | -- | -- | -366.92 | -- | -- | -- | -- | -- | -- | -- | 68.80 | -- | -- | -- |
| Eom Pharmaceutical Holdings Inc | 0.00 | -4.93m | 22.73m | 3.00 | -- | -- | -- | -- | -0.0435 | -0.0435 | 0.00 | -0.0212 | -- | -- | -- | 0.00 | -- | -126.34 | -- | -171.37 | -- | -- | -- | -- | -- | -- | 7.41 | -- | -- | -- | -254.37 | -- | -- | -- |
| Neuphoria Therapeutics Inc | 15.00m | -5.66m | 22.97m | 7.00 | -- | 0.7713 | -- | 1.53 | -2.12 | -2.12 | 5.77 | 5.52 | 0.5478 | -- | 26.19 | 2,142,857.00 | -20.68 | -35.39 | -22.63 | -39.01 | -- | -- | -37.76 | -375.66 | -- | -4.22 | 0.0011 | -- | -- | 246.65 | 97.61 | -- | -- | -- |
| Exicure Inc | 0.00 | -9.23m | 23.07m | 8.00 | -- | 3.33 | -- | -- | -3.07 | -3.07 | 0.00 | 1.09 | 0.00 | -- | -- | 0.00 | -71.27 | -44.45 | -94.78 | -60.08 | -- | -- | -- | -259.52 | -- | -- | 0.00 | -- | -- | -17.34 | 42.65 | -- | -- | -- |
| LAMY | 0.00 | 106.70k | 23.10m | -- | 24.05 | -- | 190.26 | -- | 0.0137 | 0.0137 | 0.00 | -0.0045 | 0.00 | -- | -- | -- | 763.23 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -67.39 | -- | 299.15 | -- | -- | -- |
| Marker Therapeutics Inc | 4.69m | -14.30m | 23.34m | 5.00 | -- | 1.27 | -- | 4.97 | -1.23 | -1.23 | 0.3683 | 1.10 | 0.2876 | -- | 3.90 | 938,996.00 | -87.60 | -57.72 | -110.67 | -69.11 | -- | -- | -304.54 | -761.28 | -- | -- | 0.00 | -- | 99.06 | 98.63 | 23.60 | -- | -- | -- |
| Linike Medical Group Ltd | 0.00 | -306.90k | 23.41m | -- | -- | -- | -- | -- | -0.1102 | -0.1102 | 0.00 | -0.153 | 0.00 | -- | -- | -- | -278.62 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -651.26 | -- | -- | -- |
| Vistagen Therapeutics Inc | 805.00k | -67.05m | 23.63m | 59.00 | -- | 0.464 | -- | 29.35 | -1.90 | -1.90 | 0.0228 | 1.29 | 0.0102 | -- | -- | 14,375.00 | -85.21 | -55.19 | -99.91 | -59.56 | -- | -- | -8,328.70 | -5,842.62 | -- | -- | 0.0074 | -- | -54.32 | -- | -75.12 | -- | -- | -- |
| IO Biotech Inc | 0.00 | -88.35m | 23.70m | 80.00 | -- | 25.20 | -- | -- | -1.34 | -1.34 | 0.00 | 0.0131 | 0.00 | -- | -- | 0.00 | -136.03 | -58.51 | -184.96 | -64.76 | -- | -- | -- | -- | -- | -- | 0.9482 | -- | -- | -- | -10.93 | -- | -- | -- |
| Skye Bioscience Inc | 0.00 | -51.23m | 24.40m | -- | -- | 0.7183 | -- | -- | -1.29 | -1.29 | 0.00 | 1.06 | 0.00 | -- | -- | -- | -83.39 | -139.20 | -94.11 | -262.81 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 29.43 | -- | -- | -- |
| Senti Biosciences Inc | 0.00 | -47.58m | 24.47m | 34.00 | -- | 3.01 | -- | -- | -2.80 | -2.80 | 0.00 | 0.3089 | 0.00 | -- | -- | 0.00 | -86.19 | -50.97 | -106.55 | -57.59 | -- | -- | -- | -2,565.78 | -- | -- | 0.00 | -- | -100.00 | -- | 36.71 | -- | -58.03 | -- |
| Evaxion A/S (ADR) | 7.65m | -5.42m | 25.12m | 46.00 | -- | -- | -- | 3.28 | -16.88 | -16.88 | 2.18 | -- | -- | -- | -- | 166,326.10 | -- | -96.54 | -- | -126.06 | -- | -- | -70.88 | -2,792.25 | -- | -- | -- | -- | 4,480.82 | -- | 52.24 | -- | -- | -- |
| Boundless Bio Inc | 0.00 | -61.76m | 25.97m | 64.00 | -- | 0.2357 | -- | -- | -16.06 | -16.06 | 0.00 | 4.92 | 0.00 | -- | -- | 0.00 | -35.93 | -- | -38.37 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -32.22 | -- | -- | -- |
Data as of Mar 03 2026. Currency figures normalised to IO Biotech Inc's reporting currency: US Dollar USD
39.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Lundbeckfond Invest A/Sas of 11 Apr 2025 | 13.95m | 19.39% |
| HBM Partners AG (Investment Management)as of 31 Dec 2024 | 5.52m | 7.68% |
| Point72 Asset Management LPas of 05 Feb 2026 | 4.03m | 5.60% |
| Ikarian Capital LLCas of 31 Dec 2025 | 1.39m | 1.93% |
| BofA Securities, Inc.as of 31 Dec 2025 | 799.95k | 1.11% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2025 | 539.18k | 0.75% |
| Beacon Pointe Advisors LLCas of 31 Dec 2025 | 506.00k | 0.70% |
| Boothbay Fund Management LLCas of 31 Dec 2025 | 451.85k | 0.63% |
| Dauntless Investment Group LLCas of 31 Dec 2025 | 451.64k | 0.63% |
| Marshall Wace LLPas of 31 Dec 2025 | 429.34k | 0.60% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
